Exosomes are possibly used as a tool of immune regulation during the dendritic cell-based immune therapy against HIV-I

Joel Henrique Ellwanger, Sergio Crovella, Edione Cristina dos Reis, Alessandra Pontillo, José Artur Bogo Chies

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Dendritic cell (DC)-based immune therapy (IT) against HIV showed variable results. It is known that different factors influence host response to DC-IT. Exosomes derived from DC are regulators of the immune system. In this context, here we hypothesize about the role of the DC-derived exosomes on the DC-IT response. Based on data from RT-PCR array genes expression (focused on the TSG101 gene, an exosome marker) and flow cytometry experiments of a DC-IT against HIV-1 clinical trial, we hypothesize that: During the DC-IT exosomes are used as an additional tool for immune system modulation. In addition, we believe that a low release of exosomes can be more beneficial for the DC-IT response than a high release of exosomes. Our data reinforce the concept that exosomes can act as an immune regulatory tool, however not in a generalized manner, but in a highly precise way. Our hypothesis is based in preliminary experimental data, thus, it should be tested using experimental and functional strategies involving a great number of patients. Once the hypothesis confirmed, the immunomodulatory role of the exosomes during DC-IT must be considered as an important factor in the (I) evaluation, (II) modulation, and (III) success of DC-IT against HIV.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
JournalMedical Hypotheses
Volume95
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Exosomes
Dendritic Cells
HIV-1
Cell- and Tissue-Based Therapy
Therapeutics
Immune System
HIV
Flow Cytometry
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Exosomes are possibly used as a tool of immune regulation during the dendritic cell-based immune therapy against HIV-I. / Ellwanger, Joel Henrique; Crovella, Sergio; dos Reis, Edione Cristina; Pontillo, Alessandra; Chies, José Artur Bogo.

In: Medical Hypotheses, Vol. 95, 01.10.2016, p. 67-70.

Research output: Contribution to journalArticle

Ellwanger, Joel Henrique ; Crovella, Sergio ; dos Reis, Edione Cristina ; Pontillo, Alessandra ; Chies, José Artur Bogo. / Exosomes are possibly used as a tool of immune regulation during the dendritic cell-based immune therapy against HIV-I. In: Medical Hypotheses. 2016 ; Vol. 95. pp. 67-70.
@article{a1f1f5cd3d0f4b1485b11c0142e1db81,
title = "Exosomes are possibly used as a tool of immune regulation during the dendritic cell-based immune therapy against HIV-I",
abstract = "Dendritic cell (DC)-based immune therapy (IT) against HIV showed variable results. It is known that different factors influence host response to DC-IT. Exosomes derived from DC are regulators of the immune system. In this context, here we hypothesize about the role of the DC-derived exosomes on the DC-IT response. Based on data from RT-PCR array genes expression (focused on the TSG101 gene, an exosome marker) and flow cytometry experiments of a DC-IT against HIV-1 clinical trial, we hypothesize that: During the DC-IT exosomes are used as an additional tool for immune system modulation. In addition, we believe that a low release of exosomes can be more beneficial for the DC-IT response than a high release of exosomes. Our data reinforce the concept that exosomes can act as an immune regulatory tool, however not in a generalized manner, but in a highly precise way. Our hypothesis is based in preliminary experimental data, thus, it should be tested using experimental and functional strategies involving a great number of patients. Once the hypothesis confirmed, the immunomodulatory role of the exosomes during DC-IT must be considered as an important factor in the (I) evaluation, (II) modulation, and (III) success of DC-IT against HIV.",
author = "Ellwanger, {Joel Henrique} and Sergio Crovella and {dos Reis}, {Edione Cristina} and Alessandra Pontillo and Chies, {Jos{\'e} Artur Bogo}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.mehy.2016.09.005",
language = "English",
volume = "95",
pages = "67--70",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Exosomes are possibly used as a tool of immune regulation during the dendritic cell-based immune therapy against HIV-I

AU - Ellwanger, Joel Henrique

AU - Crovella, Sergio

AU - dos Reis, Edione Cristina

AU - Pontillo, Alessandra

AU - Chies, José Artur Bogo

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Dendritic cell (DC)-based immune therapy (IT) against HIV showed variable results. It is known that different factors influence host response to DC-IT. Exosomes derived from DC are regulators of the immune system. In this context, here we hypothesize about the role of the DC-derived exosomes on the DC-IT response. Based on data from RT-PCR array genes expression (focused on the TSG101 gene, an exosome marker) and flow cytometry experiments of a DC-IT against HIV-1 clinical trial, we hypothesize that: During the DC-IT exosomes are used as an additional tool for immune system modulation. In addition, we believe that a low release of exosomes can be more beneficial for the DC-IT response than a high release of exosomes. Our data reinforce the concept that exosomes can act as an immune regulatory tool, however not in a generalized manner, but in a highly precise way. Our hypothesis is based in preliminary experimental data, thus, it should be tested using experimental and functional strategies involving a great number of patients. Once the hypothesis confirmed, the immunomodulatory role of the exosomes during DC-IT must be considered as an important factor in the (I) evaluation, (II) modulation, and (III) success of DC-IT against HIV.

AB - Dendritic cell (DC)-based immune therapy (IT) against HIV showed variable results. It is known that different factors influence host response to DC-IT. Exosomes derived from DC are regulators of the immune system. In this context, here we hypothesize about the role of the DC-derived exosomes on the DC-IT response. Based on data from RT-PCR array genes expression (focused on the TSG101 gene, an exosome marker) and flow cytometry experiments of a DC-IT against HIV-1 clinical trial, we hypothesize that: During the DC-IT exosomes are used as an additional tool for immune system modulation. In addition, we believe that a low release of exosomes can be more beneficial for the DC-IT response than a high release of exosomes. Our data reinforce the concept that exosomes can act as an immune regulatory tool, however not in a generalized manner, but in a highly precise way. Our hypothesis is based in preliminary experimental data, thus, it should be tested using experimental and functional strategies involving a great number of patients. Once the hypothesis confirmed, the immunomodulatory role of the exosomes during DC-IT must be considered as an important factor in the (I) evaluation, (II) modulation, and (III) success of DC-IT against HIV.

UR - http://www.scopus.com/inward/record.url?scp=84988353640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988353640&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2016.09.005

DO - 10.1016/j.mehy.2016.09.005

M3 - Article

AN - SCOPUS:84988353640

VL - 95

SP - 67

EP - 70

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

ER -